Direct regulation of TWIST by HIF-1α promotes metastasis
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Stabilization of the hypoxia-inducible factor-1alpha (HIF-1alpha) transcription complex, caused by intratumoural hypoxia, promotes tumour progression and metastasis, leading to treatment failure and mortality in different types of human cancers. The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis. Notably, HIF-1alpha- and TWIST-null mice show similarities in their phenotypes. Here, we have shown that hypoxia or overexpression of HIF-1alpha promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes. We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter. However, siRNA-mediated repression of TWIST in HIF-1alpha-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes. Co-expression of HIF-1alpha, TWIST and Snail in primary tumours of patients with head and neck cancers correlated with metastasis and the worst prognosis. These results provide evidence of a key signalling pathway involving HIF-1alpha and TWIST that promotes metastasis in response to intratumoural hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia and HIFs contribute to EMT by upregulating transcriptional repressors such as SNAIL (Imai et al., 2003), TWIST (Yang et al., 2008), TCF3, ZFHX1A, and ZFHX1B (Krishnamachary et al., 2006), whose gene products in turn repress CDH1.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Yang et al., 2008
In the citing paper
“Achieving vascular normalization, and thereby reducing tumour hypoxia and acidosis, is crucial because these stressors confer cancer cells with an invasive metastatic phenotype72”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [72]
In the citing paper
“Studies have demonstrated that HIF has a direct regulatory effect on EMT‐related proteins, such as zinc finger E‐box binding homeobox 1, Snail and Twist.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [85]
In the citing paper
“In experimental models, overexpression of HIF in tumor cells promotes metastasis”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
In the citing paper
“Hypoxia or overexpression of HIF is sufficient to induce EMT and invasion in multiple cell types”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Intratumoural hypoxia, followed by stabilization and activation of the HIF-1α transcription complex, is one of the most important mechanisms that promotes metastasis and thereby, increases tumour aggressivenes”
BackgroundCancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247 · cited 1×
“dtd" [ ]> Tumour metastasis is the primary cause of death for most cancer patient”
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 1×
“EMT, one of the central mechanisms that induces invasion and metastasis of tumours, is a process by which epithelial cells lose their polarity and are converted to a mesenchymal phenotyp”
BackgroundTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855 · cited 1×
“Recently, TWIST was shown to be essential in mediating cancer metastasi”
BackgroundCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundCellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Mutant phenotypes of HIF-1α - and TWIST -null mice show similarities, including defects in somites and abnormal formation of neural fold”
Background
Cited by
Items 101–200 of 1,000
The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia
Schietke, R., Warnecke, C., Wacker, I., Schödel, J., Mole, D. R., Campean, V., Amann, K., Goppelt-Struebe, M., Behrens, J., Eckardt, K.-U., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042424 · Cited by 253
Zhang, W., Shi, X., Peng, Y., Wu, M., Zhang, P., Xie, R., Wu, Y., Yan, Q., Liu, S., & Wang, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129603 · Cited by 261
Self-citationLoges, S., Schmidt, T., & Carmeliet, P. (2010) · Genes & Cancer · doi:10.1177/1947601909356574 · Cited by 257
Mitophagy in tumorigenesis and metastasis
Poole, L. P., & Macleod, K. F. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03774-1 · Cited by 241
hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Gee, H. E., Camps, C., Buffa, F. M., Patiar, S., Winter, S. C., Betts, G., Homer, J., Corbridge, R., Cox, G., West, C. M. L., et al. (2010) · Cancer · doi:10.1002/cncr.25009 · Cited by 248
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
Barzegar Behrooz, A., Talaie, Z., Jusheghani, F., Łos, M. J., Klonisch, T., & Ghavami, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031353 · Cited by 240
Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt027 · Cited by 248
Tanabe, A., Tanikawa, K., Tsunetomi, M., Takai, K., Ikeda, H., Konno, J., Torigoe, T., Maeda, H., Kutomi, G., Okita, K., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.022 · Cited by 246
Chen, Y., Li, H., Huang, C., Twu, N., Yen, M., Wang, P., Chou, T., Liu, Y., Chao, K., & Yang, M. (2010) · The Journal of Pathology · doi:10.1002/path.2761 · Cited by 245
Self-citationQiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Hypoxia: Signaling the Metastatic Cascade
Rankin, E. B., Nam, J.-M., & Giaccia, A. J. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.05.006 · Cited by 239
Zhou, G., Dada, L. A., Wu, M., Kelly, A., Trejo, H., Zhou, Q., Varga, J., & Sznajder, J. I. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2009 · Cited by 241
“It has been shown that HIF is sufficient to induce EMT in other cell types (14, 39, 51).”
BackgroundSelf-citationCancer Stem Cells, Hypoxia and Metastasis
Hill, R. P., Marie-Egyptienne, D. T., & Hedley, D. W. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.12.002 · Cited by 238
Liao, T., & Yang, M. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12096 · Cited by 239
Self-citationCycling hypoxia: A key feature of the tumor microenvironment
Michiels, C., Tellier, C., & Feron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 237
VEGF as a potential target in lung cancer
Frezzetti, D., Gallo, M., Maiello, M. R., D’Alessio, A., Esposito, C., Chicchinelli, N., Normanno, N., & De Luca, A. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1371137 · Cited by 235
Oncofetal H19 RNA promotes tumor metastasis
Matouk, I. J., Raveh, E., Abu-lail, R., Mezan, S., Gilon, M., Gershtain, E., Birman, T., Gallula, J., Schneider, T., Barkali, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.023 · Cited by 235
Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling
Lin, Y.-T., & Wu, K.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00632-3 · Cited by 229
Self-citationMonoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Wu, J. B., Shao, C., Li, X., Li, Q., Hu, P., Shi, C., Li, Y., Chen, Y.-T., Yin, F., Liao, C.-P., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70982 · Cited by 230
“Nuclear/cytoplasmic and mitochondrial/cytoplasmic extracts used took into account other possible mechanisms that may contribute to TWIST1 activation in the MAOA context, such as HIF1α activation of TWIST1 by binding directly to a hypoxia-response element in the TWIST1 promoter as described in a recent study (67).”
Phenotypic plasticity and epithelial‐mesenchymal transitions in cancer and normal stem cells?
Scheel, C., & Weinberg, R. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26311 · Cited by 233
Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
Ohshima, K., & Morii, E. (2021) · Metabolites · doi:10.3390/metabo11010028 · Cited by 220
“For example, HIF signaling induces EMT through the regulation of the EMT transcription factors SNAIL, ZEB1, and TWIST [63,64].”
BackgroundCancer drug resistance induced by EMT: novel therapeutic strategies
De Las Rivas, J., Brozovic, A., Izraely, S., Casas-Pais, A., Witz, I. P., & Figueroa, A. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03063-7 · Cited by 229
NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2008) · International Reviews of Immunology · doi:10.1080/08830180802276179 · Cited by 226
EMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Giannoni, E., Parri, M., & Chiarugi, P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4280 · Cited by 231
MicroRNA‐138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF‐1α
Yeh, Y., Chuang, C., Chao, K., & Wang, L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28086 · Cited by 231
RAC1 activation mediates Twist1-induced cancer cell migration
Yang, W.-H., Lan, H.-Y., Huang, C.-H., Tai, S.-K., Tzeng, C.-H., Kao, S.-Y., Wu, K.-J., Hung, M.-C., & Yang, M.-H. (2012) · Nature Cell Biology · doi:10.1038/ncb2455 · Cited by 231
Self-citationEpithelial to mesenchymal transition in head and neck squamous cell carcinoma
Smith, A., Teknos, T. N., & Pan, Q. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.10.009 · Cited by 226
“2).8 Epithelial cells are characterized by stable cell–cell contacts and the formation of adherents junctions.5 These junctions and contacts are predominantly E-Cadherin-dependent and connect to actin filaments through a- or b-catenin.5 Loss of E-Cadherin and relocalization of b-catenin from the membrane to the nucleu…”
BackgroundInfluentialDe Wever, O., Pauwels, P., De Craene, B., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C., Bracke, M., & Berx, G. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0464-1 · Cited by 229
“The loss of E-cadherin expression at the transcript level was Wrst identiWed in several human cancer cell lines and later in diVerent human cancers, including prostate, breast, colorectal and thyroid cancers (Reviewed in Van Aken et al. 2001; Strumane et al. 2004).”
BackgroundEpithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., & Gilles, C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9174-0 · Cited by 227
“It has been observed that hypoxia-induced factor HIF1α, a key effector of hypoxia, activates Twist, Snail and SIP1 expression, thereby leading to E-cadherin repression [36–38].”
BackgroundWei, S. C., & Yang, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.09.009 · Cited by 225
Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
Wong, P.-P., Demircioglu, F., Ghazaly, E., Alrawashdeh, W., Stratford, M. R. L., Scudamore, C. L., Cereser, B., Crnogorac-Jurcevic, T., McDonald, S., Elia, G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.10.015 · Cited by 223
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
van den Beucken, T., Koch, E., Chu, K., Rupaimoole, R., Prickaerts, P., Adriaens, M., Voncken, J. W., Harris, A. L., Buffa, F. M., Haider, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6203 · Cited by 229
Twist-1 regulates the miR-199a/214 cluster during development
Lee, Y.-B., Bantounas, I., Lee, D.-Y., Phylactou, L., Caldwell, M. A., & Uney, J. B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn920 · Cited by 226
Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
Kahlert, U. D., Nikkhah, G., & Maciaczyk, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.010 · Cited by 219
Wong, C. C.-L., Zhang, H., Gilkes, D. M., Chen, J., Wei, H., Chaturvedi, P., Hubbi, M. E., & Semenza, G. L. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0855-y · Cited by 225
Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer
Faget, J., Groeneveld, S., Boivin, G., Sankar, M., Zangger, N., Garcia, M., Guex, N., Zlobec, I., Steiner, L., Piersigilli, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.052 · Cited by 222
Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 216
Liang, X., Chen, M., Bhattarai, P., Hameed, S., & Dai, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c05617 · Cited by 219
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
Theys, J., Jutten, B., Habets, R., Paesmans, K., Groot, A. J., Lambin, P., Wouters, B. G., Lammering, G., & Vooijs, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.044 · Cited by 221
“We and others have shown previously that activation of the bHLH protein and EMT regulator Twist1 is a part of conserved response of animal cells to hypoxia [13,23].”
BackgroundGarg, M. (2013) · World Journal of Stem Cells · doi:10.4252/wjsc.v5.i4.188 · Cited by 209
Signaling pathways in renal cell carcinoma
Banumathy, G., & Cairns, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13247 · Cited by 221
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A., & Del Río Hernández, A. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 214
“This increased Twist expression also leads to IL-6 production by the breast cancer cells [171].”
BackgroundInfluentialJie, X.-X., Zhang, X.-Y., & Xu, C.-J. (2017) · Oncotarget · doi:10.18632/oncotarget.18277 · Cited by 208
Role of epithelial-mesenchymal transition in gastric cancer initiation and progression
Peng, Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5403 · Cited by 206
el Azzouzi, H., Leptidis, S., Dirkx, E., Hoeks, J., van Bree, B., Brand, K., McClellan, E. A., Poels, E., Sluimer, J. C., van den Hoogenhof, M. M. G., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.009 · Cited by 204
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
D’Ignazio, L., Batie, M., & Rocha, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020021 · Cited by 205
“Also, HIF-1α upregulation of Twist in response to hypoxia or HIF-1α overexpression induce EMT and metastatic phenotypes [139].”
BackgroundBulle, A., & Lim, K.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00341-1 · Cited by 201
Hung, J.-J., Yang, M.-H., Hsu, H.-S., Hsu, W.-H., Liu, J.-S., & Wu, K.-J. (2009) · Thorax · doi:10.1136/thx.2009.115691 · Cited by 207
Self-citationHypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Saxena, K., Jolly, M. K., & Balamurugan, K. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100845 · Cited by 206
Lisanti, M. P., Martinez-Outschoorn, U. E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A. K., Lin, Z., Balliet, R. M., Howell, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13370 · Cited by 199
Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis
Low-Marchelli, J. M., Ardi, V. C., Vizcarra, E. A., van Rooijen, N., Quigley, J. P., & Yang, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0653 · Cited by 190
Lan, X., She, J., Lin, D.-A., Xu, Y., Li, X., Yang, W.-F., Lui, V. W. Y., Jin, L., Xie, X., & Su, Y.-X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12926 · Cited by 197
Yeh, H.-W., Hsu, E.-C., Lee, S.-S., Lang, Y.-D., Lin, Y.-C., Chang, C.-Y., Lee, S.-Y., Gu, D.-L., Shih, J.-H., Ho, C.-M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0062-y · Cited by 196
A three-dimensional in vitro model of tumor cell intravasation
Ehsan, S. M., Welch-Reardon, K. M., Waterman, M. L., Hughes, C. C. W., & George, S. C. (2014) · Integrative Biology · doi:10.1039/c3ib40170g · Cited by 196
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Wei, Q., Qian, Y., Yu, J., & Wong, C. C. (2020) · Oncogene · doi:10.1038/s41388-020-01432-7 · Cited by 191
Hypoxia-regulated target genes implicated in tumor metastasis
Tsai, Y.-P., & Wu, K.-J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-102 · Cited by 190
“One well-studied aspect of hypoxia-induced metastasis is that hypoxia induces various transcriptional regulators (also called EMT regulators) to cause EMT [13] [14] [15] [16] .”
BackgroundSelf-citationTargeted genes and interacting proteins of hypoxia inducible factor-1.
Liu, W., Shen, S. M., Zhao, X., & Chen, G. Q. (2012) · Europe PMC (PubMed Central) · Cited by 260
Yang, D.-C., Yang, M.-H., Tsai, C.-C., Huang, T.-F., Chen, Y.-H., & Hung, S.-C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023965 · Cited by 181
Self-citationHypoxia-induced epithelial to mesenchymal transition in cancer
Hapke, R. Y., & Haake, S. M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.012 · Cited by 178
“Other models observe that TWIST1 levels remain unchanged, while other EMTTFs are induced under hypoxia[174].”
BackgroundInfluentialThe role of hypoxia in inflammatory disease (Review)
BIDDLESTONE, J., BANDARRA, D., & ROCHA, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2079 · Cited by 175
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
Rupaimoole, R., Wu, S. Y., Pradeep, S., Ivan, C., Pecot, C. V., Gharpure, K. M., Nagaraja, A. S., Armaiz-Pena, G. N., McGuire, M., Zand, B., et al. (2014) · Nature Communications · doi:10.1038/ncomms6202 · Cited by 181
Harada, H., Inoue, M., Itasaka, S., Hirota, K., Morinibu, A., Shinomiya, K., Zeng, L., Ou, G., Zhu, Y., Yoshimura, M., et al. (2012) · Nature Communications · doi:10.1038/ncomms1786 · Cited by 180
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00004-5 · Cited by 176
“HIF also induces the expression of Twist by binding directly to the HRE within its proximal promoter and thus mediates hypoxia-induced EMT in breast cancer, nasopharyngeal cancer, and lung tumor cells (Gort et al., 2007; Yang et al., 2008).”
BackgroundBao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression
Xu, Y., Qin, L., Sun, T., Wu, H., He, T., Yang, Z., Mo, Q., Liao, L., & Xu, J. (2017) · Oncogene · doi:10.1038/onc.2016.286 · Cited by 173
TWISTing an embryonic transcription factor into an oncoprotein
Ansieau, S., Morel, A.-P., Hinkal, G., Bastid, J., & Puisieux, A. (2010) · Oncogene · doi:10.1038/onc.2010.92 · Cited by 167
The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Filatova, A., Acker, T., & Garvalov, B. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.008 · Cited by 167
Molecular targeting of hypoxia in radiotherapy
Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 172
Hypoxia‐mediated biological control
Cassavaugh, J., & Lounsbury, K. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22956 · Cited by 169
Huang, Z., Zhang, Z., Zhou, C., Liu, L., & Huang, C. (2022) · MedComm · doi:10.1002/mco2.144 · Cited by 166
Jo, M., Lester, R. D., Montel, V., Eastman, B., Takimoto, S., & Gonias, S. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023960 · Cited by 175
The biology of head and neck cancer stem cells
Zhang, Z., Filho, M. S., & Nör, J. E. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2011.10.004 · Cited by 172
“head and neck tumors correlates with metastasis and poor prognosis.(77) Overexpression of TrkB, a 145-KDa receptor tyrosine kinase, results in EMT and enhances invasion of human HNSCC.”
InfluentialKey molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review
Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.007 · Cited by 174
“E-cadherin is direct mediator of cell–cell adhesive interactions [28] and lso provides functions in intracellular signaling, by creating complex with -catenin that affects the GTPases activty and regulates EGFR activity through receptor tyrosine inases (RTKs).”
BackgroundThe Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation
Viñas-Castells, R., Beltran, M., Valls, G., Gómez, I., García, J. M., Montserrat-Sentís, B., Baulida, J., Bonilla, F., de Herreros, A. G., & Díaz, V. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065995 · Cited by 170
Cancer stem cells and EMT in carcinoma
Biddle, A., & Mackenzie, I. C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9345-0 · Cited by 168
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Fedele, M., Sgarra, R., Battista, S., Cerchia, L., & Manfioletti, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020800 · Cited by 171
Bui, B. P., Nguyen, P. L., Lee, K., & Cho, J. (2022) · Cancers · doi:10.3390/cancers14246054 · Cited by 194
“HIF-1 directly induces the transcription of Snail [77], ZEB1 [78], TWIST [79], and TCF3 [80], whose gene products, in turn, repress E-cadherin expression.”
BackgroundPaving the Rho in cancer metastasis: Rho GTPases and beyond
Jansen, S., Gosens, R., Wieland, T., & Schmidt, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.002 · Cited by 167
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Davies, A., Zoubeidi, A., Beltran, H., & Selth, L. A. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0225 · Cited by 182
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
Xu, X., Tan, X., Tampe, B., Sanchez, E., Zeisberg, M., & Zeisberg, E. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636944 · Cited by 168
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168
Multiple biological functions of Twist1 in various cancers
Zhao, Z., Rahman, M. A., Chen, Z. G., & Shin, D. M. (2017) · Oncotarget · doi:10.18632/oncotarget.14608 · Cited by 168
“Since then, the relationship between Twist1-induced EMT and cancer metastasis has been verified in a broad range of tumor types including hepatocellular carcinoma (HCC) [24], prostate cancer [77], gastric cancer [22], esophageal squamous cell carcinoma [25, 35], bladder cancer [19], pancreatic cancer [55], gliomas [30…”
BackgroundInfluentialPhilip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
Weeraratne, S. D., Amani, V., Teider, N., Pierre-Francois, J., Winter, D., Kye, M. J., Sengupta, S., Archer, T., Remke, M., Bai, A. H. C., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0969-5 · Cited by 158
Hypoxia-regulated microRNAs in human cancer
Shen, G., Li, X., Jia, Y.-F., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.195 · Cited by 164
Sun, T., Sun, B.-C., Zhao, X.-L., Zhao, N., Dong, X.-Y., Che, N., Yao, Z., Ma, Y.-M., Gu, Q., Zong, W.-K., et al. (2011) · Hepatology · doi:10.1002/hep.24543 · Cited by 162
The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis
Qin, L., Liu, Z., Chen, H., & Xu, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4389 · Cited by 163
“of these transcription factors have been shown to regulate Twist promoter (27, 30).”
BackgroundGlaviano, A., Lau, H., Carter, L. M., Lee, E. H. C., Lam, H. Y., Okina, E., Tan, D. J. J., Tan, W., Ang, H. L., Carbone, D., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01634-6 · Cited by 183
Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
Lindsey, S., & Langhans, S. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00358 · Cited by 159
Hwang-Verslues, W. W., Chang, P.-H., Jeng, Y.-M., Kuo, W.-H., Chiang, P.-H., Chang, Y.-C., Hsieh, T.-H., Su, F.-Y., Lin, L.-C., Abbondante, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222684110 · Cited by 159
Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2009) · PubMed · Cited by 186
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Tanabe, S., Quader, S., Cabral, H., & Ono, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00904 · Cited by 161
“It has been demonstrated that the in vitro exposure of several human carcinoma cell lines induces EMT, likely due to mechanisms associated with HIF-1 activation (Imai et al., 2003; Lester et al., 2007; Yang et al., 2008).”
Backgroundvan Staalduinen, J., Baker, D., ten Dijke, P., & van Dam, H. (2018) · Oncogene · doi:10.1038/s41388-018-0378-x · Cited by 158
“For instance, HIF-1α activates TWIST expression by directly binding to the proximal promoter of the TWIST gene [44].”
BackgroundMartinez-Outschoorn, U. E., Whitaker-Menezes, D., Pavlides, S., Chiavarina, B., Bonuccelli, G., Trimmer, C., Tsirigos, A., Migneco, G., Witkiewicz, A. K., Balliet, R. M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13817 · Cited by 155
Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., Migliore, C., Giordano, S., & Chiarugi, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.042 · Cited by 172
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 157
Hsu, D. S.-S., Lan, H.-Y., Huang, C.-H., Tai, S.-K., Chang, S.-Y., Tsai, T.-L., Chang, C.-C., Tzeng, C.-H., Wu, K.-J., Kao, J.-Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0593 · Cited by 152
Self-citationvan Mil, A., Grundmann, S., Goumans, M., Lei, Z., Oerlemans, M. I. F. J., Jaksani, S., Doevendans, P. A., & Sluijter, J. P. G. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs003 · Cited by 154
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
Tsai, Y.-P., Chen, H.-F., Chen, S.-Y., Cheng, W.-C., Wang, H.-W., Shen, Z.-J., Song, C., Teng, S.-C., He, C., & Wu, K.-J. (2014) · Genome biology · doi:10.1186/s13059-014-0513-0 · Cited by 152
“Hypoxia induces the epithelial-mesenchymal transition (EMT) to promote cancer metastasis [3-6].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J.
- Affiliations
- National Yang Ming University (TW)
- Taipei Veterans General Hospital (TW)
- Mackay Memorial Hospital (TW)
- National Taiwan University (TW)
- Corresponding author
- Wu, Kou-Juey
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 295-305
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2134361367
- Cited by
- 1,345
- References
- 41
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 62 · 2023: 63 · 2022: 73 · 2021: 104 · 2020: 74 · 2019: 66 · 2018: 82 · 2017: 80 · 2016: 96 · 2015: 82 · 2014: 89 · 2013: 94 · 2012: 76
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- HIF-1α, Twist, metastasis, epithelial-mesenchymal transition, hypoxia response element, transcriptional regulation, snails, head and neck cancer, tumor progression
- MeSH terms
- Snail Family Transcription Factors, Cell Communication, Cell Differentiation, Humans, Neoplasm Metastasis, Neoplasms, Nuclear Proteins, Phenotype, Prognosis, Transcription Factors, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.